Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

First large-scale study of diabetic alert dogs published
Medical alert dog Magic with handler Claire.
Detection dogs can 'significantly improve' quality of life for diabetic owners 

Specially trained alert dogs can detect 83 per cent of hypoglycaemic episodes in patients with diabetes, according to new research.

In the first large-scale study of its kind, researchers from the University of Bristol and the charity Medical Detection Dogs found that alert dogs have the potential to significantly improve quality of life for people with type 1 diabetes.

The team studied 27 trained glycaemia alert dogs, whose owners supplied six to 12 weeks’ worth of blood records – equating to more than 4,000 hypo- and hyper-glycaemic episodes – detailing each time the dog alerted.

Commenting on the results, which were published in PLOS ONE, Dr Nicola Rooney said: “Our research shows a dog’s effectiveness is affected by the individual dog and its connection with its human partner.

“Since the usage of such dogs is growing, it’s important that any dogs used for these purposes are professionally trained, matched and monitored by professional organisations like Medical Detection Dogs.  It’s also vital that research continues both to assess true efficacy and determine ways to optimise their performance.”

Medical Detection Dogs trains pet dogs to show alerting behaviours in response to the odour produced by human disease. In diabetic patients, dogs will alert when their owners’ blood sugar level falls too low, allowing them to take the appropriate action.

Image © Trevor Martin
 

 

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.